MCM
REGN icon

MAI Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

MAI Capital Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.19M Buy
6,715
+358
+6% +$244K 0.02% 519
2026
Q1 		$4.91M Buy
6,357
+874
+16% +$669K 0.03% 411
2025
Q4 		$4.23M Buy
5,483
+4,455
+433% +$3.03M 0.02% 434
2025
Q3 		$578K Buy
1,028
+21
+2% +$11.9K ﹤0.01% 872
2025
Q2 		$529K Buy
1,007
+114
+13% +$63.6K ﹤0.01% 831
2025
Q1 		$566K Sell
893
-2,318
-72% -$1.59M ﹤0.01% 783
2024
Q4 		$2.29M Sell
3,211
-570
-15% -$478K 0.02% 461
2024
Q3 		$3.97M Sell
3,781
-250
-6% -$278K 0.04% 287
2024
Q2 		$4.24M Buy
4,031
+36
+0.9% +$34.9K 0.04% 282
2024
Q1 		$3.85M Buy
3,995
+2,845
+247% +$2.71M 0.04% 289
2023
Q4 		$1.01M Sell
1,150
-23
-2% -$18.9K 0.01% 459
2023
Q3 		$965K Buy
1,173
+45
+4% +$35.4K 0.01% 439
2023
Q2 		$811K Buy
1,128
+161
+17% +$124K 0.01% 479
2023
Q1 		$795K Buy
967
+136
+16% +$103K 0.01% 485
2022
Q4 		$600K Buy
831
+48
+6% +$35.4K 0.01% 562
2022
Q3 		$539K Buy
783
+179
+30% +$113K 0.01% 530
2022
Q2 		$357K Buy
604
+294
+95% +$191K 0.01% 645
2022
Q1 		$217K Sell
310
-54
-15% -$34.2K ﹤0.01% 806
2021
Q4 		$230K Buy
+364
New +$224K ﹤0.01% 785

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

MAI Capital Management's REGN Position: Q2 2026 in Review

MAI Capital Management increased its Regeneron Pharmaceuticals (REGN) stake by 5.6% in Q2 2026, buying an estimated $244K and bringing the position to 6,715 shares worth $4.19M. The position accounts for 0.02% of the portfolio, ranked #519.

MAI Capital Management first reported a position in REGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $4.91M in Q1 2026. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • MAI Capital Management held 6,715 shares of Regeneron Pharmaceuticals worth $4.19M as of Q2 2026.
  • MAI Capital Management bought 358 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $244K.
  • Regeneron Pharmaceuticals made up 0.02% of MAI Capital Management's portfolio in Q2 2026, its #519 holding.
  • MAI Capital Management first reported a position in Regeneron Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • MAI Capital Management's Regeneron Pharmaceuticals position peaked at $4.91M in Q1 2026.
  • 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.